Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Its FDA label specifies sterile water, but that is regulatory convention, not the gentler diluent
Our full medical weight loss program ties these pieces together and adjusts the plan as your body responds
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
You need to enable JavaScript to run this app.
US$ 27.49
US$ 28.36
US$ 27.42
US$ 25.98
